In Jun-2022, a new achievement was reached by Virginia Contract Research Organization Co., Ltd. (VCRO). A biotech company, which was assisted by VCRO, was granted a cell therapy product phase I/IIa IND clinical-go to treat Solid Tumor from the FDA. The professional, integrated, and local team of VCRO successfully helped customers to achieve the next step of product commercialization.
Congratulation! TCR-T Cells therapy to treat Solid Tumor was granted by the US FDA IND!
In Jun-2022, a new achievement was reached by Virginia Contract Research Organization Co., Ltd. (VCRO). A biotech company, which was assisted by VCRO, was granted a cell therapy product phase I/IIa IND clinical-go to treat Solid Tumor from the FDA. The professional, integrated, and local team of VCRO successfully helped customers to achieve the next step…